VeriMomБезопасен ли cordyceps sinensis mycelium extract при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- Безопасен ли cordyceps sinensis mycelium extract при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
- Безопасен ли cordyceps sinensis mycelium extract при грудном вскармливании?
- No evidence from regulatory listings or authoritative safety assessments (CIR/SCCS/ECHA Annex VI) of transfer into breastmilk or lactation-specific toxicity. Mechanistic data indicating placental or milk transfer are lacking; therefore no mechanistic concern is assigned. Low but measurable systemic absorption is possible from topical use, so exposure to nursing mother is considered low (e=1). Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Безопасен ли cordyceps sinensis mycelium extract для кожи малыша?
- No infant-specific reproductive or developmental toxicity data were identified and no regulatory flags for developmental toxicity exist. Mechanistic concerns for infant skin are not identified. Because infant skin has higher surface‑area‑to‑weight and a less mature barrier, exposure score is increased by +1 relative to adult (adult e=1 → baby e=2) to reflect higher potential per‑kg uptake from topical application of extracts containing small molecules. Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Как VeriMom оценивает cordyceps sinensis mycelium extract?
- VeriMom оценивает cordyceps sinensis mycelium extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы cordyceps sinensis mycelium extract при беременности?
- См. наш список безопасных альтернатив cordyceps sinensis mycelium extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.